Kopp T - Search Results

1

Clinical and cytological effects of pimecrolimus cream 1% after resolution of active atopic dermatitis lesions by topical corticosteroids: a randomized controlled trial.

Bangert C, Strober BE, Cork M, Ortonne JP, Luger T, Bieber T, Ferguson A, Ecker RC, Kopp T, Weise-Riccardi S, Guettner A, Stingl G. Bangert C, et al. Among authors: kopp t. Dermatology. 2011 Feb;222(1):36-48. doi: 10.1159/000321711. Epub 2010 Dec 8. Dermatology. 2011. PMID: 21150167 Clinical Trial.

2

Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis.

Hoetzenecker W, Ecker R, Kopp T, Stuetz A, Stingl G, Elbe-Bürger A. Hoetzenecker W, et al. Among authors: kopp t. J Allergy Clin Immunol. 2005 Jun;115(6):1276-83. doi: 10.1016/j.jaci.2005.02.011. J Allergy Clin Immunol. 2005. PMID: 15940147 Clinical Trial.

3

Ustekinumab treatment in severe atopic dermatitis: Down-regulation of T-helper 2/22 expression.

Weiss D, Schaschinger M, Ristl R, Gruber R, Kopp T, Stingl G, Bangert C. Weiss D, et al. Among authors: kopp t. J Am Acad Dermatol. 2017 Jan;76(1):91-97.e3. doi: 10.1016/j.jaad.2016.07.047. Epub 2016 Oct 13. J Am Acad Dermatol. 2017. PMID: 27745907

4

Immunopathologic features of allergic contact dermatitis in humans: participation of plasmacytoid dendritic cells in the pathogenesis of the disease?

Bangert C, Friedl J, Stary G, Stingl G, Kopp T. Bangert C, et al. Among authors: kopp t. J Invest Dermatol. 2003 Dec;121(6):1409-18. doi: 10.1111/j.1523-1747.2003.12623.x. J Invest Dermatol. 2003. PMID: 14675191 Free article.

5

Dendritic cells in atopic dermatitis: expression of FcepsilonRI on two distinct inflammation-associated subsets.

Stary G, Bangert C, Stingl G, Kopp T. Stary G, et al. Among authors: kopp t. Int Arch Allergy Immunol. 2005 Dec;138(4):278-90. doi: 10.1159/000088865. Epub 2005 Oct 7. Int Arch Allergy Immunol. 2005. PMID: 16220004

6

Serum IgE autoantibodies target keratinocytes in patients with atopic dermatitis.

Altrichter S, Kriehuber E, Moser J, Valenta R, Kopp T, Stingl G. Altrichter S, et al. Among authors: kopp t. J Invest Dermatol. 2008 Sep;128(9):2232-9. doi: 10.1038/jid.2008.80. Epub 2008 May 15. J Invest Dermatol. 2008. PMID: 18480840 Free article.

7

Tildrakizumab for the treatment of psoriasis.

Bangert C, Kopp T. Bangert C, et al. Among authors: kopp t. Immunotherapy. 2018 Sep;10(13):1105-1122. doi: 10.2217/imt-2018-0028. Epub 2018 Aug 7. Immunotherapy. 2018. PMID: 30081696 Review.

8

Analysis of the prodynorphin promoter polymorphism in atopic dermatitis and disease-related pruritus.

Greisenegger EK, Zimprich A, Zimprich F, Stingl G, Kopp T. Greisenegger EK, et al. Among authors: kopp t. Clin Exp Dermatol. 2009 Aug;34(6):728-30. doi: 10.1111/j.1365-2230.2009.03225.x. Epub 2009 May 26. Clin Exp Dermatol. 2009. PMID: 19486061

9

Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells.

Stary G, Bangert C, Tauber M, Strohal R, Kopp T, Stingl G. Stary G, et al. Among authors: kopp t. J Exp Med. 2007 Jun 11;204(6):1441-51. doi: 10.1084/jem.20070021. Epub 2007 May 29. J Exp Med. 2007. PMID: 17535975 Free PMC article.

10

Analysis of four prevalent filaggrin mutations (R501X, 2282del4, R2447X and S3247X) in Austrian and German patients with atopic dermatitis.

Greisenegger E, Novak N, Maintz L, Bieber T, Zimprich F, Haubenberger D, Gleiss A, Stingl G, Kopp T, Zimprich A. Greisenegger E, et al. Among authors: kopp t. J Eur Acad Dermatol Venereol. 2010 May;24(5):607-10. doi: 10.1111/j.1468-3083.2009.03469.x. Epub 2009 Oct 23. J Eur Acad Dermatol Venereol. 2010. PMID: 19874431

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters